Data from phase Ib and II trials presented at the 17th World Conference on Lung Cancer (WCLC) show promising efficacy of nivolumab and pembrolizumab in patients with malignant mesothelioma, a highly aggressive cancer with poor prognosis and limited treatment options after progression on platinum-containing chemotherapy.
Icotinib improves progression-free survival (PFS) and objective response rate (ORR) vs whole-brain irradiation (WBI) plus chemotherapy in Chinese patients with non-small-cell lung cancer (NSCLC) and brain metastases, according to a phase III study presented recently at the 17th World Conference on Lung Cancer (WCLC).
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Doctor - Malaysia digital copy today!
Systolic blood pressure appears to have a strong association with aneurysmal subarachnoid haemorrhage (aSAH) but not with unruptured intracranial aneurysm (UIA), whereas current smoking and female sex are risk factors for both conditions, a study has found.